EOS IMAGING The Annual Financial Report is now available to the public, and has been registered with the Autorité des marchés financiers.
The Annual Financial Report is available at the registered office of the company (10 rue Mercœur - 75011 Paris) and on the EOS imaging's website at www.eos-imaging.com in the section "Investors / Documentation / Financial Reports".
For more information, please visit www.eos-imaging.com.
EOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.EOS imaging is listed on Compartment C of Euronext Paris ISIN: FR0011191766 - Ticker: EOSI
Next press release: 2016 First-half sales on July 28, 2016 About EOS imagingEOS imaging designs, develops, and markets EOS®, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopaedics, as well as associated solutions. The Company is authorized to market in 51 countries, including the United States (FDA), Japan, China, and the European Union (EC). The Group posted 2015 revenues of €21.8 million and employs 107 people including an R&D team of 39 engineers. The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.
Contacts:
Anne RenevotCFO
Ph: +33 (0)1 55 25 61 24
investors@eos-imaging.com
NewCapFinancial communication and investor relations Valentine Brouchot
Ph: +33 (0)1 44 71 94 96
eosimaging@newcap.eu
The Ruth Group (US)Press relations / Joanna Zimmerman Ph: 646-536-7006
jzimmerman@theruthgroup.com
EOS imaging SA issued this content on 29 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 02 May 2016 07:28:02 UTC. Original document available at http://www.eos-imaging.com/uploads/PDFs/press/2016/160429_Annual%20Financial%20Report_vf.pdf |
